Moves on the part of Amazon and Google to enter the financial services market are prompting European financial regulators to mull whether or not the tech companies need to be supervised.
According to a report in the Financial Times citing Olli Rehn, governor of Finland’s central bank and a member of the European Central Bank’s governing council, the issue of tech companies entering the financial services industry has resulted in a “very lively discussion by financial supervisors and central banks in Europe.” The comments were made at the Financial Times’ Middle East Banking Forum being held in Dubai. It was well received by senior bankers, reported the paper, noting many have complained that it’s not an even playing field when competing against technology companies. The report noted it could also mark a new fight between tech companies and European regulators, which have been going after them over data breaches and to get more taxes out of the tech giants.
Rehn was asked if the ECB was mulling regulation for the tech companies that have entered financial services and said in response: “we see big tech is moving in there,” adding that it was “currently a matter for discussion among financial supervisors,” reported the Financial Times.
The comments come as the big tech companies in the US including Amazon, Google, Facebook, and Apple have been entering the financial services market by supporting digital payments and launching other services. Tencent and Alibaba in China are also leaders in digital payments and are expanding into financial services as well. Earlier this year financial regulators in the EU opened up banking to FinTechs, requiring lenders to provide access to accounts of customers that authorized third parties to have access. European banks are concerned that US and Chinese technology heavy-hitters will enter the best parts of the financial services market and not face the same regulation to which they are subject.
Featured News
Meta Begins Defense After FTC Concludes Case in Landmark Antitrust Trial
May 15, 2025 by
CPI
UK Data Bill Still No Closer to Passage As Parliamentary ‘Ping-Pong’ Drags On
May 15, 2025 by
CPI
Regeneron Pharmaceuticals Awarded $271.2M in Damages Against Amgen
May 15, 2025 by
CPI
FTC Chair Proposes 15% Staff Reduction Amid Budget Constraints
May 15, 2025 by
CPI
UK Urges Antitrust Watchdog to Prioritize Growth and Clarity in Business Regulation
May 15, 2025 by
CPI
Antitrust Mix by CPI
Antitrust Chronicle® – Healthcare Antitrust
May 14, 2025 by
CPI
Healthcare & Antitrust: What to Expect in the New Trump Administration
May 14, 2025 by
Nana Wilberforce, John W O'Toole & Sarah Pugh
Patent Gaming and Disparagement: Commission Fines Teva For Improperly Protecting Its Blockbuster Medicine
May 14, 2025 by
Blaž Višnar, Boris Andrejaš, Apostolos Baltzopoulos, Rieke Kaup, Laura Nistor & Gianluca Vassallo
Strategic Alliances in the Pharma Sector: An EU Competition Law Perspective
May 14, 2025 by
Christian Ritz & Benedikt Weiss
Monopsony Power in the Hospital Labor Market
May 14, 2025 by
Kevin E. Pflum & Christian Salas